1. Home
  2. TCRT vs LCFY Comparison

TCRT vs LCFY Comparison

Compare TCRT & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

N/A

Current Price

$1.57

Market Cap

7.8M

Sector

Health Care

ML Signal

N/A

Logo Locafy Limited

LCFY

Locafy Limited

N/A

Current Price

$0.97

Market Cap

8.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TCRT
LCFY
Founded
1998
2009
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
8.3M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
TCRT
LCFY
Price
$1.57
$0.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 4.5M
17.6K
Earning Date
11-24-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 24.66
N/A
EPS
N/A
★ N/A
Revenue
★ $15,900,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.85
52 Week High
$4.50
$6.20

Technical Indicators

Market Signals
Indicator
TCRT
LCFY
Relative Strength Index (RSI) 45.54 30.34
Support Level $1.02 N/A
Resistance Level $1.96 $1.21
Average True Range (ATR) 0.20 0.08
MACD -0.08 0.02
Stochastic Oscillator 13.60 28.65

Price Performance

Historical Comparison
TCRT
LCFY

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

About LCFY Locafy Limited

Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.

Share on Social Networks: